270 likes | 281 Vues
Explore COPD prevalence among Londoners, treatment recommendations for primary care, interpreting APHO profiles, smoking cessation impact, and aligning data for better outcomes. Discover evidence-based interventions for COPD management.
E N D
Primary Care Intelligence A GP Perspective with a COPD focus Dr Noel Baxter, Surrey Docks Health Centre & London Respiratory Team
COPD in London: what do we know? 7,619,800 Londoners Mid-2008 population estimate How many are living with COPD?
Right Care Priorities • Stop smoking support and therapy as treatment for COPD • Pulmonary Rehabilitation • Responsible Respiratory Prescribing • Responsible Oxygen Prescribing
Using APHO Profiles in COPD COPD in Primary Care… A slow awakening Getting motivated Changing attitudes Less interest in LOS/Admissions
Using APHO Profiles What works well… Adds value to QOF data Compare practices using local knowledge Visually useful for overall picture
Using APHO Profiles What needs to be reviewed… QOF too easily achieved Not enough reds and greens Looks like everyone the same
COPD 13: A review including MRC score Not required for QOF
COPD 10 &12: FEV1 at diagnosis and every 15 months Not required for QOF Not required for QOF
Evidence based therapy Not required for QOF Not required for QOF
www.audit-commission.gov.uk 09/10Exception rate (%) No of exceptions CVD primary prevention 18.97 119,103 Heart failure 17.23 93,808 COPD 12.65 348,939 Mental health 10.80 102,104 Epilepsy 7.82 77,80
Exception reporting in COPD Nihilism in both parties Housebound – Silo working Confusion around diagnostic criteria Is it a marker for quality of care?
Exception reporting review All years: 13 patients exception reported without valid justification 8: Conflict about diagnosis 1: Patient too frail 4: No clear justification
Interpreting APHO Profiles Achieved QOF for ‘ inappropriate’ exception reported patients
COPD measures in primary care (Wish list) • Prevalence of smokers in COPD register • Offer and provision of effective stop smoking treatment • Prescribing data • Measuring outcomes • Completion of pulmonary rehabilitation • Quit smoking at 1 year • PROM • Hypoxia Assessed • CO Measured • Stratification using MRC scores
Stopping smoking works… Fletcher, Peto: Br Med J 1977; 1 :
Long-term effectiveness and costeffectiveness of smoking cessation interventions in patients with COPD Tiotropium QALY £7,112 Eur J Health Econ. 2007; 8(2): 123135 Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mo¨lken MPMH Thorax 2010: 65:711-718
Explaining Variance Current Smokers
Explaining Variance Never Smoked
What do we know:Smoking prevalence in ‘COPD’? At best one in four Londoners with COPD are still smokers….
2009-2010 Smoking history distribution of a GP COPD List (n=111)
2009-2010 Smoking history distribution of a Tiotropium treated COPD List (n=52)
League Table Anxiety Performance - LMC Being open and supportive Motivating presentation of data Shifting resources Using revalidation
Consortia need help to measureprimary care outcomes in COPD Annual prevalence of current smoking in COPD register % offered evidence based Stop smoking therapy % MRC 3 who were referred / completed PR % MRC score 3 or more with Pulsoximetry result Patient satisfaction of COPD care Consortia costs/per practice costs Admissions per practice